Aarti Pharmalabs Limited

Listed manufacturer of active pharmaceutical ingredients, intermediates and xanthine derivatives, demerged from the Aarti group in 2019, with over 200 products and 500 clients. Six production units and two R&D centres: Dombivli for chiral chemistry and nucleosides, Vapi for custom synthesis, and four Tarapur plants covering xanthines — caffeine, theophylline, etofylline — general APIs, corticosteroids and oncology products.